PBX1 promotes osteoporosis by upregulating HMGB1 to suppress osteogenic differentiation of bone marrow mesenchymal stem cells.
1/5 보강
[BACKGROUND] Osteoporosis is a common skeletal disorder characterized by low bone mass and impaired bone formation, driven in part by defective osteogenic differentiation of bone marrow mesenchymal st
APA
Yang Y, Liu Z (2025). PBX1 promotes osteoporosis by upregulating HMGB1 to suppress osteogenic differentiation of bone marrow mesenchymal stem cells.. Stem cell research & therapy, 16(1), 695. https://doi.org/10.1186/s13287-025-04832-2
MLA
Yang Y, et al.. "PBX1 promotes osteoporosis by upregulating HMGB1 to suppress osteogenic differentiation of bone marrow mesenchymal stem cells.." Stem cell research & therapy, vol. 16, no. 1, 2025, pp. 695.
PMID
41291922 ↗
Abstract 한글 요약
[BACKGROUND] Osteoporosis is a common skeletal disorder characterized by low bone mass and impaired bone formation, driven in part by defective osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).
[METHODS] Transcriptomic profiling, molecular biology techniques, functional assays, and pharmacological inhibition were used to investigate the regulatory role and downstream effects of candidate genes during BMSC osteogenic differentiation.
[RESULTS] Transcriptome-based screening identified Pre-B-cell leukemia homeobox 1 (PBX1) as a candidate gene consistently upregulated in samples with low bone mass. During osteogenic induction, PBX1 expression declined progressively, inversely correlating with classical osteogenic markers. Functional experiments demonstrated that PBX1 knockdown enhanced expression of Runt-related transcription factor 2 (RUNX2), Osterix (OSX), and Osteocalcin (OCN), increased Alkaline phosphatase (ALP) activity, and reduced apoptosis, while PBX1 overexpression exerted the opposite effects. Mechanistically, PBX1 directly bound to the proximal promoter of High mobility group box 1 (HMGB1) and transcriptionally activated its expression. Rescue experiments revealed that overexpression of HMGB1 partially reversed the enhanced osteogenesis caused by PBX1 knockdown, confirming HMGB1 as a downstream effector. Time-course transcriptomic analysis and gene network correlation further linked PBX1 to pathways involving inflammation, cellular aging, and stemness maintenance. Pharmacological inhibition of PBX1 with TCRS-417 resulted in dose-dependent downregulation of both PBX1 and HMGB1, while significantly restoring osteogenic gene expression and mineralization capacity, underscoring its therapeutic potential for promoting bone formation in osteoporotic conditions.
[CONCLUSION] PBX1 acts as an upstream transcriptional regulator that suppresses osteogenic differentiation in part by activating HMGB1, and pharmacological inhibition of PBX1 restores osteogenic potential.
[METHODS] Transcriptomic profiling, molecular biology techniques, functional assays, and pharmacological inhibition were used to investigate the regulatory role and downstream effects of candidate genes during BMSC osteogenic differentiation.
[RESULTS] Transcriptome-based screening identified Pre-B-cell leukemia homeobox 1 (PBX1) as a candidate gene consistently upregulated in samples with low bone mass. During osteogenic induction, PBX1 expression declined progressively, inversely correlating with classical osteogenic markers. Functional experiments demonstrated that PBX1 knockdown enhanced expression of Runt-related transcription factor 2 (RUNX2), Osterix (OSX), and Osteocalcin (OCN), increased Alkaline phosphatase (ALP) activity, and reduced apoptosis, while PBX1 overexpression exerted the opposite effects. Mechanistically, PBX1 directly bound to the proximal promoter of High mobility group box 1 (HMGB1) and transcriptionally activated its expression. Rescue experiments revealed that overexpression of HMGB1 partially reversed the enhanced osteogenesis caused by PBX1 knockdown, confirming HMGB1 as a downstream effector. Time-course transcriptomic analysis and gene network correlation further linked PBX1 to pathways involving inflammation, cellular aging, and stemness maintenance. Pharmacological inhibition of PBX1 with TCRS-417 resulted in dose-dependent downregulation of both PBX1 and HMGB1, while significantly restoring osteogenic gene expression and mineralization capacity, underscoring its therapeutic potential for promoting bone formation in osteoporotic conditions.
[CONCLUSION] PBX1 acts as an upstream transcriptional regulator that suppresses osteogenic differentiation in part by activating HMGB1, and pharmacological inhibition of PBX1 restores osteogenic potential.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Super-selective intra-arterial dissolution therapy for lingual artery occlusion resulting due to the use of hyaluronic acid for chin augmentation: The first reported case.
- NAT10 and ac4C modification in cancer immunity and metabolism: emerging mechanisms and therapeutic potential.
- Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists.
- HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGFβ1 expression and inhibit hepatocellular carcinoma metastasis.
- Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Temporal dynamics of mesenchymal stem cell administration influence immune modulation in a 4T1 breast cancer model.
- Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats.
- Trans-activator of transcription-pre-B-cell leukemia transcription factor 1 alleviates Alzheimer's disease by reducing neuronal insulin resistance and restoring energy homeostasis.
- Immunomediator expression in human periodontal ligament MSCs varies depending on surface CD146 expression.
- Dihydrocapsaicin Secreted by RYK Silenced Bone Marrow-Derived Mesenchymal Stem Cells Triggers Apoptosis of Gastric Cancer Cells.
- Exosomal lncRNA SILC1 from bicalutamide-activated mesenchymal stem cells promotes prostate cancer survival and bicalutamide resistance via the miR-577/RHOA axis.